Cargando…
Revisiting a Null Hypothesis: Exploring the Parameters of Oligometastasis Treatment
PURPOSE: In the treatment of patients with metastatic cancer, the current paradigm states that metastasis-directed therapy does not prolong life. This paradigm forms the basis of clinical trial null hypotheses, where trials are built to test the null hypothesis that patients garner no overall surviv...
Autores principales: | Scarborough, Jessica A., Tom, Martin C., Kattan, Michael W., Scott, Jacob G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122026/ https://www.ncbi.nlm.nih.gov/pubmed/33484786 http://dx.doi.org/10.1016/j.ijrobp.2020.12.044 |
Ejemplares similares
-
Diagnosis of oligometastasis
por: Terao, Mayako, et al.
Publicado: (2020) -
microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015) -
Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019) -
OLIGOMETASTASIS IN GASTRIC CANCER TREATMENT: IS THERE A PLACE FOR THE SURGEON?
por: de ASSUMPÇÃO, Paulo Pimentel, et al.
Publicado: (2023) -
Defining the null hypothesis
por: Saxon, Emma
Publicado: (2015)